Companies: 10,795·Total market cap: $144.5T
Laxai Pharma, Ltd.

Laxai Pharma, Ltd.

LAXAFOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$475341
P/E Ratio
52W High
52W Low

Laxai Pharma, Ltd. (LAXAF) Market Cap & Net Worth

Live market cap, enterprise value, and global rank — multi-year chart and annual table below.

laxaf · market cap & enterprise value · FMP · as of Apr 5, 2023

Core market cap & key metrics

As of Apr 5, 2023, Laxai Pharma, Ltd. (LAXAF) has a market cap — also referred to as its net worth or valuation — of $475,341, making it one of the top most valuable companies globally. Market Cap = $0.00 × shares outstanding.

Market Cap (Net Worth)$475,341laxaf market cap 2026
Enterprise ValuemktCap + debt − cash
1-Year Changevs one year ago
Global Rankinglargest company by mkt cap
All-Time High$0laxaf highest market cap ever
Stock Price$0.00OTC · Apr 5, 2023
How is Market Cap calculated?Market Cap = Stock Price × Shares Outstanding

About Market Cap, Net Worth & Valuation

Laxai Pharma, Ltd. (LAXAF) has a market cap — also referred to as its net worth or valuation — of $475,341 as of Apr 5, 2023, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.

Laxai Pharma, Ltd. reached its all-time high market cap of $0 on —. Comparing the Laxai Pharma, Ltd. market cap history illustrates one of the most extraordinary corporate growth stories.

Investors frequently compare Laxai Pharma, Ltd. net worth vs peers and ask how Laxai Pharma, Ltd. valuation compares to other countries. Its market cap reflects continued investor confidence.

Data: FMP · year-end market cap · not investment advice

Frequently Asked Questions

LAXAF market cap · 6 questions

Laxai Pharma, Ltd.'s net worth — measured as market capitalization — is $475,341 as of Apr 5, 2023. It ranks #0 globally. Market Cap = $$0.00 (price) × shares outstanding.

LAXAF net worth 2026market cap vs book valuelargest companies by market cap
Data: Financial Modeling Prep · Market cap updates daily · For informational purposes only, not investment advice.